Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone added to standard treatment for children with empyema
IRCT20240705062336N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexamethasone in empyema (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Length of hospitalization, Oxygen saturation and 2 more. Started Jun 2023; status: completed.
02
Drugs
dexamethasone
03
Conditions
empyema
Beyond the preview
Go deeper on IRCT20240705062336N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240705062336N1.